Aspire BioPharma is trading 5.4% down at $6.36 following yesterday’s sharp rebound, with no new company-specific news driving today’s move.
- The decline appears to be driven by normal volatility and profit-taking after opportunistic buying lifted shares nearly 20% on July 30.
- The stock remains highly volatile due to its extremely low market cap and limited float, which often results in double-digit daily swings.